We have developed virus-inspired nanoparticles that deliver RNA-based vaccines and therapeutics without refrigeration. By mimicking how viruses naturally protect and deliver genetic material, our platform achieves room-temperature stability and lower doses, eliminating cold-chain dependence and making next-generation RNA medicines accessible to patients worldwide, including in low-resource settings.
Take a look at the finalists across the four competition categories
Find out more